From: Patterns of inflammation and the use of reversibility testing in smokers with airway complaints
COPD n = 17 | Asthma n = 11 | CB n = 14 | HS n = 17 | |
---|---|---|---|---|
Age (range) | 61.4 (41–74) | 57.6 (36–73) | 53.9 (34–72) | 54.6 (42–64) |
Gender (f/m) | 2/15* | 3/8 | 5/9 | 11/6* |
Smoking status (former/current) | 6/11 | 5/6 | 4/10 | 7/10 |
Packyears | 48.4* (29) | 23.1* (20) | 33.5 (18) | 32.3 (13) |
FEV1/FVC postBD | 0.56 (0.13)* | 0.70 (0.17) | 0.73 (0.2) | 0.77 (0.22)* |
FEV1 postBD (%pred) | 59.0* (17) | 82.1 (17) | 100.7* (17) | 103.9* (19) |
BD-Reversibility (Δ FEV1 %pred) | 3.5 (9) | 12.1* (7) | 4.5 (5) | 4.9 (4) |